English | Español
Patient Daily | May 7, 2023

Ten Centura Hospitals Awarded Spring 2023 ‘A’ Hospital Safety Grade from Leapfrog Group
Patient Daily | May 7, 2023

Centura Health to Distribute $5 Million in Grants through the Equity & Advancement Fund
Patient Daily | May 7, 2023

CommonSpirit Health Welcomes Utah to Its Connected Ecosystem of Hospitals and Clinics
Patient Daily | May 7, 2023

EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS
Patient Daily | May 7, 2023

Stryker completes acquisition of Cerus Endovascular
Patient Daily | May 7, 2023

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily | May 7, 2023

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Patient Daily | May 7, 2023

Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients

Trending
Patient Daily | Jul 15, 2025

Scottsdale Sinus & Allergy Center garners 500+ Google reviews with a 4.9-star rating
Patient Daily | Jul 11, 2025

Physician assistant on headaches and sinusitis: ‘Sinus headaches are known to trigger your migraines’
Patient Daily | Jul 15, 2025

Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating
+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'